What is the share price of Ambu?
The share price of Ambu A/S (traded on NASDAQ OMX Copenhagen under the symbol AMBU-B) is approximately 73.50 DKK. Ambu is a prominent Danish company that develops, manufactures, and markets hospital diagnostic and single-use visualization devices, anesthesia equipment, and patient monitoring solutions to healthcare professionals worldwide. Its stock performance reflects ongoing global trends in medical device manufacturing, hospital capital expenditure cycles, research and development investments, supply chain dynamics, and regulatory approvals across key international healthcare markets. Investors typically monitor Ambu's financial health by analyzing key metrics such as its price-to-earnings ratio, operating margins, recurring revenue streams from single-use medical products, and broader healthcare sector sentiment.
Related FAQs
Ambu A/S is an authentic and historic Danish multinational medical device enterprise founded, headquartered, and operating primarily in Ballerup, Denmark.
Financial analysts tracking Ambu A/S provide comprehensive twelve-month price predictions and consensus forecasts that fluctuate in response to macroeconomic models, quarterly earnings reports, and international medical device market trends.
Ambu A/S was founded in Denmark in 1937 by Holger Hesse, originally starting as an enterprise focused on medical device innovation, most notably pioneering the self-inflating manual resuscitator known as the Ambu Bag.
Ambu A/S is a global medical technology company headquartered in Ballerup, Denmark, situated in the Copenhagen capital region.
Ambu A/S is an authentic, publicly traded corporate entity listed on Nasdaq Copenhagen, where its shares are actively bought and sold by institutional investment funds, mutual funds, and retail shareholders.
Ambuja Cements distributes regular dividend payments to its eligible shareholders, operating as a well-established dividend-paying industrial entity listed on Indian stock exchanges.
Ambu A/S is a specialized Danish medical technology company headquartered in Ballerup, Denmark, globally recognized as a pioneer in the development, production, and marketing of single-use diagnostic and visualization medical devices.
Analyzing the price volatility of AMETEK, Inc.—a leading global manufacturer of electronic instruments and electromechanical devices—reveals a low to moderate volatility profile.
Ambu, a prominent global medical technology enterprise headquartered in Denmark, cultivates a dynamic corporate culture anchored on core principles of innovation, empathy, sustainability, and close collaboration with healthcare professionals.
Ambu A/S is publicly listed on the Nasdaq Copenhagen stock exchange (formerly the Copenhagen Stock Exchange), trading under the ticker symbol AMBU B.
Assessing Ambu A/S as an equity investment involves analyzing secular growth trends in single-use medical devices, hospital infection control priorities, and international market penetration.
Estimating the five-year outlook for Bank of America shares requires examining broader monetary policy trends, loan portfolio growth, wealth management inflows, and digital banking platform efficiencies.
Ambu specializes in the design, development, and manufacture of innovative single-use medical devices for hospitals, clinics, and emergency medical services worldwide.
Ambu A/S operates as a specialized medical technology enterprise focused on developing, manufacturing, and marketing single-use medical devices and diagnostic solutions for healthcare providers worldwide.
Equity research coverage for Ambuja Cements Limited features a consensus 12-month average price target averaging around 655.00 Indian rupees per share, with bull-case targets scaling up to 840.00 Indian rupees.